Business Offer

2017/07/31

United States

This antibody-cytokine fusion protein was achieved by conjugating/fusing the Anti-EpCAM IgG to IL2. It was expressed in CHO and purified with affinity chromatography. The immunocytokine retains the ability to bind the EpCAM as well as the biological activity of IL2.

This antibody-cytokine fusion protein was achieved by conjugating/fusing the Anti-EpCAM IgG to IL2. It was expressed in CHO and purified with affinity chromatography. The immunocytokine retains the ability to bind the EpCAM as well as the biological activity of IL2. The huKS-muγ2a-muIL2 fusion protein was constructed by replacing the human antibody constant regions and human IL2 of the huKS-huγ1-huIL2 fusion protein. This immunocytokine was designed for treating solid tumor. http://www.creativebiolabs.net/Anti-EpCAM-Immunocytokine-IgG-huKS-IL2-22503.htm

[RequestAdvantages]

[RequestComments]

389

Creative Biolabs